Augmentin maintained its position as the top-selling brand with Rs 75-80 crore in monthly sales, contributing significantly to the overall market. Certain therapy areas outperformed the overall pharma ...
GlaxoSmithKline Pharma has been benefitting from rising market share for its antibiotic Augmentin and respiratory drugs Nucala and Trelegy. Strong demand for its vaccine for shingles, Shingrix, has ...
For further results highlights, click. GlaxoSmithKline Pharma has been benefitting from rising market share for its antibiotic Augmentin and respiratory drugs Nucala and Trelegy. Strong demand for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback